Join us for the 10th biennial meeting of the Australasian Virology Society in Queenstown, New Zealand. Our meeting serves to showcase basic, translational and clinical virology and will be attended by over 150 leading researchers from Australia, New Zealand and across the globe. The meeting is an opportunity to discuss a range of issues covering emerging disease threats, control of virus disease, vaccine development and implementation studies, diagnosis of disease and diagnostic development. Uniquely, we aim to bridge basic, translational and clinical research in animal, plant and human health.
Breakfast Workshop Sponsor
The Australian Centre for Hepatitis Virology (ACHV) is an incorporated body of biomedical scientists throughout Australia with the common interest of promoting and disseminating research into all aspects of the hepatitis and related viruses. Our aim is to improve the quality of research, communication and collaboration amongst member laboratories, advocate for more funding for basic and translational research, raise awareness of hepatitis viruses and associated diseases, provide scholarships for early career researchers to attend National and International hepatitis meetings, provide advice to government, medical and community bodies, and support and promote hepatitis meetings in Australia and Internationally.
BD is a global medical technology company that is advancing the world of health by improving the medical discovery, diagnostics and the delivery of care. In diagnostics, BD supplies instrumentation and consumables for Microbiology, Molecular and Cytology testing, and is a leading provider of products for the safe collection and transport of diagnostics specimens. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
For more information on BD, please visit www.bd.com
Burnet Institute is an Australian, independent, not-for-profit organisation. Its mission is to achieve better health for vulnerable communities by accelerating the translation of research, discovery and evidence into sustainable health solutions.
Burnet brings together a highly diverse skill base of medical researchers, public health and international development professionals (including one of the largest groups of virologists in Australia) with a key focus on Maternal and Child Health, Disease Elimination, Behaviours and Health Risks, Health Security, and Healthy Ageing.
Many challenges we face as a society are the consequence of stresses that we place on our natural world. Our goal, in the School of Biological Sciences, is to understand how stresses impact on our health and the health of our planet, and to design innovative solutions that improve ecological, environmental or health outcomes. To achieve this, we have assembled an exceptional group of academics, and are training the future leaders. in life sciences.
As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. We are devoted to protecting people and communities across the globe – working each and every day with our partners on the front line of public health.
The Webster Centre for Infectious Diseases is a virtual centre based at the University of Otago that is dedicated to supporting basic research in infectious diseases throughout New Zealand.
Our primary mission is to provide molecular solutions to problems in infectious diseases through the application of modern methods of molecular and translational research. In turn, we hope that this progress will lead to the development of new vaccines, diagnostics and antimicrobials.
Session and Award Sponsors
The Institute for Glycomics at Griffith University is one of Australia’s flagship multidisciplinary biomedical research institutes. Established in 2000, it strives to be a world leader in the discovery and development of next generation drugs, vaccines and diagnostics for diseases of global impact. The Institute engages with industry, premier research institutes, philanthropic organisations and governments across the globe, with a primary focus on translational research that will inevitably have a positive impact on human health.
The journal Cellular Microbiology, a leader in the field of microbiology, host-pathogen interactions and innate immunity, is celebrating its 20th anniversary this year. We aim to publish outstanding contributions to the understanding of interactions between microbes, prokaryotes and eukaryotes, and their host in the context of pathogenic or mutualistic relationships, including co-infections and microbiota. We welcome studies on single cells, animals and plants, and encourage the use of model hosts and organoid cultures.
Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why the University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.
Viruses (ISSN 1999-4915) is an open access journal which provides an advanced forum for studies of viruses. We aim to help researchers present their cutting-edge findings and opinions in detail and have quick dissemination among their peers. Original articles, reviews, communications, conference reports and short notes are all welcome.
Committed to making the discoveries that will relieve the future burden of disease, the newly established Monash Biomedicine Discovery Institute at Monash University brings together more than 120 internationally-renowned research teams. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.
The School of Chemistry and Molecular Biosciences at UQ teaches and researches in the disciplines of Chemistry, Biochemistry, Biotechnology and Microbiology. Our research has contributed to scientific advances as diverse as safer vaccines, improved diagnosis and early detection of breast cancer. Our graduates benefit from a strong culture of teaching innovation and student-industry placement, making them job-ready and well-informed about recent developments in science and technology.
The Australian Infectious Diseases Research Centre (AIDRC) is a multidisciplinary network based at The University of Queensland and the QIMR Berghofer Medical Research Institute. It includes more than 100 research groups with expertise in virology, bacteriology, parasitology and clinical research. AIDRC’s mission is to utilize leading technologies to identify, understand and prevent infectious diseases.
The ASM is a not-for-profit organisation, formed in 1959 as a learned society devoted to furthering the science of microbiology. In 1976, the ASM became an incorporated professional society, and has a membership approaching 2000. The society functions in “bringing microbiologists together” with the objective of advancing the science of microbiology in Australia.
La Trobe University has established Centre for Livestock interactions with Pathogens (CLiP) which brings together critical mass of researchers at La Trobe University to generate a complete “Bench to Barn” research program focusing on 1) field deployable diagnostics, 2) molecular understanding of disease pathogenesis 3) sustainable treatment solution (vaccines and breeding).
The Department of Microbiology and Immunology, University of Melbourne is located at the Doherty Institute. It comprises more than 120 academic staff, including 18 full Professors, 96 graduate students and 35 research groups that are actively involved in microbiology and immunology research and teaching. The Department of Microbiology and Immunology prides itself on excellence in research focused on mechanisms of infection and immunity (particularly viral infections such as Influenza, HIV, HCV, Norovirus and flavivirus infections) and the development of new approaches to control and treat infectious diseases.
The Maurice Wilkins Centre is New Zealand’s Centre of Research Excellence targeting cancer, metabolic disease and infectious disease. As the national hub for molecular biodiscovery the Centre provides a point of contact for a broad range of national scientific expertise. It cultivates collaborations with international researchers and research institutions and also engages with industry and the medical profession. It is committed to building the economy, and building scale in the New Zealand biomedical sector and encourages innovative fundamental science that has the potential for high impact on human health.
Microorganisms (ISSN 2076-2607, Impact Factor 4.167) is a SCIE-indexed, peer-reviewed, open access microbiology journal, which provides an advanced forum for studies related to prokaryotic and eukaryotic microorganisms, viruses, and prions. It publishes reviews, research papers, and communications. There is no restriction on the length of the papers.
Thermo Fisher Scientific is the world leader in serving science, enabling customers to make the world healthier, cleaner and safer. Our comprehensive range includes high-end analytical and process instrumentation, laboratory equipment, a complete range of consumables, chemicals and reagents as well as the service and support to optimise your results.